Clinical Trials › NCT05634967
Recruiting
Kesimpta (Ofatumumab) Pregnancy Registry
Sponsored by Novartis Pharmaceuticals
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 725
Target enrollment
1
U.S. states
Jan 2023
Start date
Feb 2033
Expected completion
Interventions / Treatments
Kesimpta
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
California1 site
La Jolla
Participating MS centers on MS Buddy (1)
UC San Diego Health MS Program
La Jolla, CA
La Jolla, CA
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.